PA
BBNX

Perceptive Advisors’s Beta Bionics BBNX Stock Holding History

Perceptive Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Sell
832,944
-10,000
-1% -$119K 0.2% 72
2026
Q1 		$8.45M Buy
842,944
+240,000
+40% +$3.55M 0.17% 69
2025
Q4 		$18.4M Buy
602,944
+325,000
+117% +$8.68M 0.33% 65
2025
Q3 		$5.52M Sell
277,944
-1,315,664
-83% -$23.1M 0.16% 70
2025
Q2 		$23.2M Hold
1,593,608
– – 0.86% 30
2025
Q1 		$19.5M Buy
+1,593,608
New +$29.7M 0.69% 37

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Perceptive Advisors's BBNX Position: Q2 2026 in Review

Perceptive Advisors reduced its Beta Bionics (BBNX) stake by 1.2% in Q2 2026, selling an estimated $119K and leaving 832,944 shares worth $13.1M. The position accounts for 0.2% of the portfolio, ranked #72.

Perceptive Advisors first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $23.2M in Q2 2025. 134 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Perceptive Advisors held 832,944 shares of Beta Bionics worth $13.1M as of Q2 2026.
  • Perceptive Advisors sold 10,000 Beta Bionics shares in Q2 2026, an estimated $119K.
  • Beta Bionics made up 0.2% of Perceptive Advisors's portfolio in Q2 2026, its #72 holding.
  • Perceptive Advisors first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Perceptive Advisors's Beta Bionics position peaked at $23.2M in Q2 2025.
  • 134 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.